We're dedicated to providing safe and effective medicines, alongside services and support for healthy outcomes. This involves superior science, creativity, and collaboration with stakeholders at all levels. As a leading pharma company in the U.S., we focus on devastating diseases and complex medical challenges across six specific therapeutic areas: Cardiovascular & Metabolism, Immunology, Infectious Diseases & Vaccines, Neuroscience, Oncology, and Pulmonary Hypertension.
The grant program aims to fund programs and initiatives that improve patient access to treatment and services, advance health equity, and strengthen frontline health workforces within specified therapeutic areas. The focus is on supporting disease awareness, patient empowerment and advocacy, linkages to care, and health system improvement with measurable outcomes. Specifically, in the area of Immunology, the grants support efforts targeted at diseases like Ankylosing Spondylitis, Crohn’s Disease, Plaque Psoriasis, Polyarticular Juvenile Idiopathic Arthritis, Psoriatic Arthritis, Rheumatoid Arthritis, and Ulcerative Colitis. Areas of interest include early disease intervention, education for patients and caregivers, wellness and family support, patient empowerment, tools for therapy improvement, professional and caregiver skill building, addressing healthcare disparities, providing direct patient services, outreach, and advocacy for access to care.